Emerging Pharmacovigilance Outsourcing Market Trends: Advanced Cloud-Based Data Lake Platform Enhances Pharmacovigilance And Safety Data Management Shaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pharmacovigilance Outsourcing Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a substantial growth in the size of the pharmacovigilance outsourcing market. This market is expected to expand from $6.16 billion in 2024 to $7.24 billion in 2025, with a compound annual growth rate (CAGR) of 17.6%. This increase during the historical period can be credited to the surge in drug development initiatives, stricter regulatory demands, a rise in adverse drug reaction instances, heightened concerns regarding patient safety, and an increase in outsourcing by small to mid-sized firms.

How Will the Pharmacovigilance Outsourcing Market Size Evolve and Grow by 2029?
In the coming years, the pharmacovigilance outsourcing market is anticipated to witness a substantial expansion. The market is projected to surge to $13.73 billion by 2029, experiencing a compound annual growth rate (CAGR) of 17.3%. The projected growth during the forecast period is primarily driven by the escalating progression of biologics and biosimilars, increased concentration on personalized medicine, an escalating demand for real-world evidence, enhanced complexity of drug safety profiles, and an intensified focus on patient-centric care. The forecast period anticipates major trends like growing utilization of big data analytics, increasing partnerships and collaborations, the inclination towards cloud-based pharmacovigilance solutions, incorporation of pharmacovigilance with digital health platforms, and the promotion of specialized pharmacovigilance services for gene therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report

What Drivers Are Propelling the Growth of Pharmacovigilance Outsourcing Market Forward?
The growth of the pharmacovigilance outsourcing market is anticipated to be boosted by the increasing amount of clinical trials taking place. Clinical trials, which test the safety, effectiveness, and potential side effects of novel treatments, drugs, or medical devices, are on the rise for multiple reasons such as a growing emphasis on precision medicine, an escalating incidence of chronic diseases, regulatory support, and research globalization. In the context of clinical trials, pharmacovigilance outsourcing aids in deepening drug safety surveillance by utilizing specialized skills and resources to maintain regulatory compliance and optimize efficiency. For example, data from the Association of the British Pharmaceutical Industry, a UK-based trade group, showed that the total count of industry-backed clinical trials initiated in the UK saw a minor rise of 4.3%, from 394 trials in 2021 to 411 in 2022, in November 2023. Hence, the escalating quantity of clinical trials is fueling the expansion of the pharmacovigilance outsourcing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp

Which Emerging Trends Are Transforming the Pharmacovigilance Outsourcing Market in 2025?
Leading businesses in the pharmacovigilance outsourcing market concentrate on producing innovative solutions such as a centralized storage system using cloud-based data lake platforms, improving pharmacovigilance case handling and safety data management methods, improving clinical research registries, and fulfilling regulatory stipulations. A cloud-based data lake platform serves as a centralized hub for storing and handling substantial quantities of unprocessed data in its original structure until it is required. Notably, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, introduced CorEvidence to boost clinical research registries. The tool is designed to simplify pharmacovigilance case processing by managing different data sources. It enhances coding, classification, and recording of adverse incidents. The key feature of this tool is it offers scalable, compliant, and audit-friendly safety management, building upon the CorEvitas clinical research registries, and assures support for comprehensive post-authorization safety studies across numerous therapeutic fields.

What Are the Key Segments in the Pharmacovigilance Outsourcing Market?
The pharmacovigilance outsourcingmarket covered in this report is segmented -

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture
2) By Service Provider: Contract Research Organization, Business Processing Outsourcing
3) By End User: Pharmaceutical Industry, Research Organization, Others End Users

Subsegments:
1) Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software
2) Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services
3) Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services
4) Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing
5) Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services
6) Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services
7) Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms
8) Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19651&type=smp

Who Are the Key Players Shaping the Pharmacovigilance Outsourcing Market's Competitive Landscape?
Major companies operating in the pharmacovigilance outsourcing market are accenture* PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (LabCorp), Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Global Pharma Tek, Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

What Geographic Markets Are Powering Growth in the Pharmacovigilance Outsourcing Market?
North America was the largest region in the pharmacovigilance outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19651

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.